AAV Genome Integrity Analysis Using CE-LIF and Benzonase Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for determining the size and purity of adeno-associated virus (AAV) genomes are time-consuming and have limited resolution, and remnants of contaminants can persist in the viral vector product, affecting treatment efficacy.
Innovation Solution
A capillary electrophoresis-based method using a kit with nucleic acid standards and enzymes like benzonase for purifying and analyzing AAV genomes, enabling detection of intact and partial genomes and removal of small size impurities.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If denaturing agarose-gel electrophoresis and southern blot are used for genome size verification, then the method is traditional and well-established, but the analysis is time-consuming and has limited resolution on size determination
Solution Approach 1:
The patent replaces the mechanical agarose-gel electrophoresis system with a capillary electrophoresis system that uses laser-induced fluorescence detection. This substitution enables automated, high-resolution genome size analysis without the time-consuming manual processing steps of traditional gel electrophoresis and southern blotting, directly resolving the contradiction between measurement precision and analysis time
Solution Approach 2:
The patent changes the detection parameters by implementing laser-induced fluorescence detection with specific excitation wavelengths (488 nm for SYBR Green I, 532 nm for YOYO-1) and optimized capillary electrophoresis conditions. These parameter changes enable rapid, high-resolution genome size determination, simultaneously improving both measurement precision and reducing analysis time compared to traditional methods
2Reliability
If gradient ultra-centrifugation is used for purification of packaged rAAV vectors, then Full capsids can be separated from cellular debris and Empty AAV capsids, but remnants of contaminants can still be present in the viral vector product
Solution Approach 1:
The patent applies benzonase enzyme treatment before capillary electrophoresis analysis to pre-digest contaminating nucleic acids. This preliminary action removes DNA and RNA contaminants that would otherwise interfere with accurate genome size determination, enhancing both purification effectiveness and eliminating harmful contaminant remnants
Solution Approach 2:
The patent uses benzonase as an intermediary enzyme that specifically degrades nucleic acid contaminants without affecting the AAV capsids. This intermediary agent enables selective removal of harmful factors (nucleic acid remnants) while preserving the viral vector integrity, resolving the contradiction between purification effectiveness and contaminant removal
3Ease of manufacture
If traditional purification methods are used, then the process is simpler, but errors in genome encapsidation lead to heterogeneous populations with both intact genome and partial or smaller than unit-length genomes
Solution Approach 1:
The patent segments the analysis process into distinct steps: benzonase treatment to digest contaminants, capillary electrophoresis for separation, and laser-induced fluorescence detection for quantification. This segmentation enables precise detection of heterogeneous genome populations while maintaining a relatively simple overall manufacturing process, resolving the contradiction between ease of manufacture and manufacturing precision
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method provides rapid and accurate determination of AAV genome size and purity, enhancing the quality of viral vectors by reducing contaminants and improving treatment efficacy.
Implementation Method 1
a capillary electrophoresis-based method using a kit with nucleic acid standards and enzymes like benzonase for purifying and analyzing AAV genomes
Implementation Method 2
separating each of the different nucleic acid strands in the standard by measuring each of the nucleic acid strands having a known size by utilizing a capillary electrophoresis-laser induced fluorescence (CE-LIF) device
Implementation Method 3
measuring the separated nucleic acid strands as intensity peaks that are a function of migration time using a detector of the CE-LIF
Implementation Method 4
treating said sample with benzonase and filtering said treated sample to remove degraded impurities
Data Source
AI summary
A CE based method and kit for the determination of the size and purity of an AAV genome which relies on Capillary Electrophoresis-Laser Induced Fluorescence (CE-LIF) analysis. These methods and kits are capable of detecting intact and partial genomes in a virus vectors such as adeno-associated viruses as well as remove small size impurities. In one example, the method can include creating a nucleic acid ladder using CE-LIF, releasing the genome from within an adeno-associated virus, purifying said genome and analyzing said genome using CE-LIF and comparing the results of the analysis of the genome to the nucleic acid ladder to determine a size of nucleic acids in the genome.